(+)-Norfenfluramine hydrochloride
SIGMA/N3288 - ≥98% (HPLC), powder
Synonym: JP 92; NSC 43036; S-(+)-α-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride
CAS Number: 37936-89-3
Empirical Formula (Hill Notation): C10H12F3N · HCl
Molecular Weight: 239.67
MDL Number: MFCD11045299
Linear Formula: C10H12F3N · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| drug control | regulated under CDSA - not available from Sigma-Aldrich Canada |
| form | powder |
| InChI | 1S/C10H12F3N.ClH/c1-7(14) |
| InChI key | PIDLOFBRTWNFAR-FJXQXJEOSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.C[C@H](N)Cc1cccc(c1)C( |
| solubility | H2O: >10 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | (+)-Norfenfluramine is the major hepatic metabolite of (+)-fenfluramine and is primarily responsible for the anorexic effect, as well as side effects; (+)-norfenfluramine causes vasoconstriction and a blood pressure increase in rats with normal blood; acts primarily on the cytoplasmic pool of serotonin; more potent than fenfluramine at inducing dopamine release. |
| Biochem/physiol Actions: | Potent substrate for serotonin transporter; 5-HT2A/2B agonist; anorectic |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352116 |


